journal article·2026-12-31Open access

Mannose-functionalized CeO₂ nanoparticles for synergistic ROS scavenging and immunomodulation in nephritis therapy

Zhiyue Cai, Jun Long, Haowen Zhang, Jie Liu, Yunjian Huang

Materials Technology· Volume 41· Issue 1

Abstract

Nephritis couples oxidative stress with immune dysregulation, demanding therapies that localize to inflamed tissue and actively neutralize reactive oxygen species (ROS). We engineered a mannose-functionalized cerium oxide nanozyme co-loaded with dexamethasone (Man-CeO₂@DEX) to unify CD206-mediated targeting with self-regenerating Ce³⁺/Ce⁴⁺ redox catalysis. In acellular assays, Man-CeO₂@DEX most strongly suppressed •OH, outperforming CeO₂ and free DEX. In LPS-primed cells, Man-CeO₂@DEX lowered IL-1β/IL-6 and enhancing macrophage repolarization. The platform couples receptor-guided cellular enrichment with catalytic, continuous ROS clearance to potentiate local glucocorticoid action while minimizing systemic exposure. These data establish Man-CeO₂@DEX as a translatable strategy for ROS-driven renal inflammation.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Advanced Nanomaterials in Catalysis · Nanoplatforms for cancer theranostics · Nephrotoxicity and Medicinal Plants

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Nephrology

Chongqing University Fuling Hospital

Funding

The Renal Disease (Internal Medicine) Construction Project of the Regional Special Disease Clinical Diagnosis and Treatment Center. · Chongqing Fuling District Science and Health Joint Medical Research Project

References (26)

Show source-provided references
1. 10.1080/10667857.2025.251966310.1080/10667857.2025.2519663 ↗
2. 10.1038/s41581-024-00820-610.1038/s41581-024-00820-6 ↗
3. 10.1080/10667857.2025.245960210.1080/10667857.2025.2459602 ↗
4. 10.1016/j.ntm.2025.10009210.1016/j.ntm.2025.100092 ↗
5. 10.1038/s41581-023-00775-010.1038/s41581-023-00775-0 ↗
6. 10.1002/adfm.20230314710.1002/adfm.202303147 ↗
7. 10.1038/s41581-022-00621-910.1038/s41581-022-00621-9 ↗
8. 10.3389/fimmu.2025.164252510.3389/fimmu.2025.1642525 ↗
9. 10.1038/s41467-023-37831-z10.1038/s41467-023-37831-z ↗
10. 10.1038/s41467-024-45477-810.1038/s41467-024-45477-8 ↗
11. 10.1681/asn.000000060810.1681/asn.0000000608 ↗
12. 10.1007/s40820-024-01477-310.1007/s40820-024-01477-3 ↗
13. 10.3390/ijms2503137010.3390/ijms25031370 ↗
14. 10.1002/advs.20210036810.1002/advs.202100368 ↗
15. 10.1093/nar/gkac30810.1093/nar/gkac308 ↗
16. 10.1080/10667857.2019.163378710.1080/10667857.2019.1633787 ↗
17. 10.1016/j.jconrel.2025.11425410.1016/j.jconrel.2025.114254 ↗
18. 10.1080/10667857.2019.163867110.1080/10667857.2019.1638671 ↗
19. 10.1002/smll.20240541710.1002/smll.202405417 ↗
20. 10.1080/10667857.2025.258103610.1080/10667857.2025.2581036 ↗
21. 10.3390/ijms25221207810.3390/ijms252212078 ↗
22. 10.1080/10667857.2024.244321110.1080/10667857.2024.2443211 ↗
23. 10.1080/10667857.2020.180284110.1080/10667857.2020.1802841 ↗
24. 10.1007/s12668-024-01617-410.1007/s12668-024-01617-4 ↗
25. 10.1016/j.matdes.2025.11507210.1016/j.matdes.2025.115072 ↗
26. 10.1016/j.cclet.2025.11181710.1016/j.cclet.2025.111817 ↗